Chordia Therapeutics
190A.TPharmaceutical
Filed as Chordia Therapeutics Inc. (2024-07–2026-04)
Major holders (5%+) · 6
| Holder | Stake |
|---|---|
| Nomura Securities Co., Ltd. | 20.05% |
| Takeda Pharmaceutical Company Limited | 16.42% |
| SBI SECURITIES Co., Ltd. | 13.87% |
| Shinsei Capital Partners, Ltd. | 11.06% |
| SBI Investment Co., Ltd. | 6.63% |
| MIYAKE HIROSHI | 5.73% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 8
| - | 4.85% |
| Kyoto University Innovation Capital Co., Ltd. | 4.68% |
| JAFCO Group Co., Ltd. | 4.53% |
| SMBC Venture Capital Co., Ltd | 4.51% |
| UTokyo Innovation Platform Co., Ltd. | 3.77% |
| Nomura SPARX Investment, Inc. | 2.61% |
| NOMURA INTERNATIONAL PLC | 0.16% |
| Sumitomo Mitsui DS Asset Management Company, Limited | 0.00% |
Ownership history · 58
| Holder | Ratio | Change |
|---|---|---|
| NOMURA INTERNATIONAL PLC2026-09-16 | 0.16% | new |
| Nomura SPARX Investment, Inc.2026-09-16 | 2.61% | -1.08pp |
| Nomura Securities Co., Ltd.2026-09-16 | 20.05% | +19.37pp |
| -2025-04-25 | 4.85% | -1.04pp |
| Nomura Securities Co., Ltd.2024-12-20 · amended | 0.68% | -0.15pp |
| Nomura SPARX Investment, Inc.2024-12-20 · amended | 3.69% | -1.90pp |
| Nomura Securities Co., Ltd.2024-12-20 · amended | 0.83% | +0.13pp |
| Nomura SPARX Investment, Inc.2024-12-20 · amended | 5.59% | -1.38pp |
| Nomura Securities Co., Ltd.2024-12-20 · amended | 0.70% | new |
| Nomura SPARX Investment, Inc.2024-12-20 · amended | 6.97% | -0.74pp |
| SMBC Venture Capital Co., Ltd2024-10-03 | 4.51% | -1.09pp |
| UTokyo Innovation Platform Co., Ltd.2024-09-27 · amended | 3.77% | -1.37pp |
| Sumitomo Mitsui DS Asset Management Company, Limited2024-09-24 | 0.00% | -0.54pp |
| SMBC Venture Capital Co., Ltd2024-09-24 | 5.60% | -0.46pp |
| -2024-09-19 | 5.89% | -0.18pp |
| UTokyo Innovation Platform Co., Ltd.2024-09-04 | 5.14% | new |
| -2024-07-23 | 6.07% | no change |
| MIYAKE HIROSHI2024-06-21 | 5.73% | new |
| JAFCO Group Co., Ltd.2024-06-21 · amended | 4.53% | -1.21pp |
| JAFCO Group Co., Ltd.2024-06-21 · amended | 5.74% | -1.58pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.